Highly consistent, top quality collagenase and neutral protease are essential tissue dissociation enzymes for tissue engineering and regenerative medicine applications
Funding will accelerate development of the company’s AI-powered antibody drug discovery technology, focused on identifying new therapeutics for cancer, heart, and lung diseases